Globus Medical Inc  

(Public, NYSE:GMED)   Watch this stock  
Find more results for GMED
-0.29 (-1.22%)
Real-time:   3:54PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 23.18 - 24.10
52 week 14.53 - 27.14
Open 24.03
Vol / Avg. 604,210.00/513,191.00
Mkt cap 2.20B
P/E 32.22
Div/yield     -
EPS 0.73
Shares 93.71M
Beta     -
Inst. own 57%
Apr 29, 2014
Q1 2014 Globus Medical Inc Earnings Conference Call - 5:30PM EDT - Add to calendar
Apr 29, 2014
Q1 2014 Globus Medical Inc Earnings Release - 4:00PM EDT - Add to calendar
Mar 11, 2014
Globus Medical Inc at Canaccord Genuity's Musculoskeletal Conference
Feb 26, 2014
Q4 2013 Globus Medical Inc Earnings Conference Call - Webcast
Feb 26, 2014
Q4 2013 Globus Medical Inc Earnings Release
Feb 12, 2014
Globus Medical Inc at Leerink Swann Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 18.21% 15.79%
Operating margin 27.55% 23.40%
EBITD margin - 33.46%
Return on average assets 15.43% 13.54%
Return on average equity 18.28% 15.98%
Employees 850 -
CDP Score - -


United States - Map
+1-610-9301800 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Globus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. As of December 31, 2011, the Company had launched over 110 products and offers a portfolio of products addressing a range of spinal pathologies, anatomies and surgical approaches. The Company's products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company's Innovative Fusion products address a range of spinal fusion surgical procedures. Spinal fusion is a surgical procedure to correct problems with the individual vertebrae, the interlocking bones making up the spine, by preventing movement of the affected bones. In July 2012, the Company acquired the assets of a small company with operations in the United States and Germany, including a new product designed to treat vertebral compression fractures (VCFs). In January 2014, Globus Medical Inc acquired Excelsius Surgical.

Officers and directors

David C. Paul Chairman of the Board, Chief Executive Officer
Age: 46
Bio & Compensation  - Reuters
David M. Demski President, Chief Operating Officer, Director
Age: 55
Bio & Compensation  - Reuters
Richard A. Baron Chief Financial Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
A. Brett Murphy Executive Vice President, US Sales
Age: 48
Bio & Compensation  - Reuters
David D. Davidar Vice President - Operations, Director
Age: 47
Bio & Compensation  - Reuters
Daniel T. Lemaitre Independent Director
Age: 59
Bio & Compensation  - Reuters
Robert W. Liptak Independent Director
Bio & Compensation  - Reuters
Ann D. Rhoads Independent Director
Age: 47
Bio & Compensation  - Reuters
Kurt C. Wheeler Independent Director
Bio & Compensation  - Reuters